1. Home
  2. ELTX vs MGYR Comparison

ELTX vs MGYR Comparison

Compare ELTX & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • MGYR
  • Stock Information
  • Founded
  • ELTX 2011
  • MGYR 1922
  • Country
  • ELTX United States
  • MGYR United States
  • Employees
  • ELTX N/A
  • MGYR N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • MGYR Savings Institutions
  • Sector
  • ELTX Health Care
  • MGYR Finance
  • Exchange
  • ELTX Nasdaq
  • MGYR Nasdaq
  • Market Cap
  • ELTX 121.7M
  • MGYR 98.9M
  • IPO Year
  • ELTX N/A
  • MGYR 2006
  • Fundamental
  • Price
  • ELTX $8.09
  • MGYR $17.15
  • Analyst Decision
  • ELTX Strong Buy
  • MGYR
  • Analyst Count
  • ELTX 2
  • MGYR 0
  • Target Price
  • ELTX $9.50
  • MGYR N/A
  • AVG Volume (30 Days)
  • ELTX 46.9K
  • MGYR 11.4K
  • Earning Date
  • ELTX 08-12-2025
  • MGYR 07-24-2025
  • Dividend Yield
  • ELTX N/A
  • MGYR 1.63%
  • EPS Growth
  • ELTX N/A
  • MGYR 19.38
  • EPS
  • ELTX N/A
  • MGYR 1.43
  • Revenue
  • ELTX N/A
  • MGYR $34,067,000.00
  • Revenue This Year
  • ELTX N/A
  • MGYR N/A
  • Revenue Next Year
  • ELTX N/A
  • MGYR N/A
  • P/E Ratio
  • ELTX N/A
  • MGYR $11.78
  • Revenue Growth
  • ELTX N/A
  • MGYR 12.12
  • 52 Week Low
  • ELTX $3.70
  • MGYR $11.25
  • 52 Week High
  • ELTX $9.99
  • MGYR $19.04
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 62.14
  • MGYR 71.26
  • Support Level
  • ELTX $7.76
  • MGYR $16.02
  • Resistance Level
  • ELTX $8.94
  • MGYR $17.10
  • Average True Range (ATR)
  • ELTX 0.37
  • MGYR 0.59
  • MACD
  • ELTX -0.03
  • MGYR 0.00
  • Stochastic Oscillator
  • ELTX 51.09
  • MGYR 37.83

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.

Share on Social Networks: